期刊文献+

急性肺血栓栓塞血浆肌钙蛋白Ⅰ的改变及其对预后的评估 被引量:3

Prognostic Value of Serum Troponin I in Acute Pulmonary Embolism
下载PDF
导出
摘要 目的 :探讨血浆肌钙蛋白I(ScTnI)对急性肺血栓栓塞预后的评估价值。方法 :分析我院近 4年确诊急性肺血栓栓塞并行ScTnI检查的患者共 3 3例 ,分为ScTnI <0 1ng/ml组 (n =2 0 )及ScTnI≥ 0 1ng/ml组 (n =13 ) ,分析ScTnI水平与转归的关系。结果 :ScTnI <0 1ng/ml组中大面积肺血栓栓塞 9例 ,次大面积 4例 ,非大面积 7例 ;合并低血压休克者 6例 ;治疗后 8例患者呼吸困难完全消失 ,11例呼吸困难基本消失 ;1例死亡。ScTnI≥ 0 1ng/ml组中大面积肺血栓栓塞 12例 ,次大面积 1例 ;合并低血压休克者 11例 ;治疗后 3例呼吸困难完全消失 ,3例呼吸困难基本消失 ,7例住院期间死亡。 2组间低血压休克发生率及病死率存在显著性差异 (P <0 0 1)。结论 :急性肺血栓栓塞ScTnI升高者预后差 ,住院期间低血压休克发生率及病死率显著升高。 Objective: To assess the value of serum cardiac troponin I(ScTnI)for prognosis of patients with acute pulmonary thromboembolism (PTE). Methods:Data of inpatients from 2000 as 2003 who conformed as acute PTE and had ScTnI detected were reviewed and divided into ScTnI<0.1 ng/ml group(n=20)and ScTnI≥0.1 ng/ml group(n=13).The prognosis of the two groups were evaluated. Results: There were 9 cases of massive PTE, 4 of sub-massive PTE and 7 of non-massive PTE in ScTnI <0.1 ng/ml group,6 of them were complicated with hypotensive shock. After treatment, dyspnea completely disappeared in 8,almost completely disappeared in 12,and one patient died. In ScTnI≥0.1 ng/ml group, 12 were of massive PTE, one of sub-massive PTE, 11 of them were complicated with hypotensive shock. After treatment, dyspnea completely disappeared in 3,almost completely in 3,7 died during hospital stay. There was significant difference in the mortality between the two groups (p<0.01). Conclusions: The level of ScTnI is significantly related to the prognosis of acute PTE.Patients with higher level of ScTnI have a higher mortality during hospital stay.
出处 《中国循环杂志》 CSCD 北大核心 2004年第1期50-52,共3页 Chinese Circulation Journal
关键词 急性肺血栓栓塞 血浆肌钙蛋白I 预后 评估 转归 Pulmonary embolism Cardiac troponin Ⅰ Prognosis
  • 相关文献

参考文献1

  • 1崔希忠 程显声 李智.急性主肺动脉缩窄肺栓塞的实验研究[A].见:程显声主编.肺动脉栓塞文集[C].北京:人民卫生出版社,.344-346.

同被引文献28

  • 1薛莉,王彦卿.心肌肌钙蛋白I与慢性心力衰竭[J].中国循环杂志,2005,20(4):244-244. 被引量:6
  • 2Giuntini C, Di Ricco G, Marini C, et al. Pulmonary embolism:epidemiology[J]. Chest, 1995, 107 (1 Suppl ) : 3S-9S.
  • 3Konstantinides S, Geibel A, Olschewski M, et al. Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism[J]. Circulation, 2002, 106: 1263- 1268.
  • 4Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry ( ICOPER). Lancet, 1999, 353: 1386-1389.
  • 5Musani MH. Asymptomatic saddle pulmonary embolism: case report and literature review. Clin Appl Thromb Hemost, 2011, 17: 337-339.
  • 6Ahintop L, Yardan T, Cander B, et al. An increase of BNP |evels in massive pulmonary embolism and the reduction in response to the acute treatment. Resuscitation, 2005, 65: 225-229.
  • 7Kucher N, Printzen G, Doernhoefer T, et al. Low pro-brain natriuretic peptide levels predict benign clinical outcome in acute pulmonary embolism. Circulation, 2003, 107:1576-1578.
  • 8Missov ED, De Marco T. Clinical insights on the use of highly sensitive cardiac troponin assays. Clin Chim Acta, 1999, 284: 175-185.
  • 9Adams JE, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury. Is MB ereatine kinase the choice for the 1990s? Circulation, 1993, 88: 750-763.
  • 10Tare JR. Troponin revisited 2008: assay performance. Clin Chem Lab Med, 2008, 46: 1489-1500.

引证文献3

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部